Lactobacillus fermentum attenuates the alveolar bone loss in ligature‐induced periodontitis in mice
Oral Diseases · 2024
DOI: 10.1111/odi.14739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Yuni Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology and Research Institute of Oral Sciences, Gangneung-Wonju National University College of Dentistry, Gangneung, Republic o…. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Limosilactobacillus fermentum, Periodontitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hecto Healthcare Co., Ltd.
Abstract (Originalsprache)
Objective
This study investigated the effects of Lactobacillus fermentum BELF11 on periodontitis in mice (LIP).
Methods
Sixty mice were randomly assigned to a control group (CTL), LIP/PBS group (LIP and PBS applied), or LIP/BELF11 group (LIP and L. fermentum BELF11 applied). For 14 days, PBS or L. fermentum BELF11 was applied twice daily to the mice in the LIP/PBS or LIP/BELF11 group, respectively. After 14 days, radiographic, histological, and pro‐inflammatory cytokine assessments were conducted.
Results
The LIP/PBS and LIP/BELF11 groups demonstrated greater alveolar bone loss than the CTL group ( p < 0.05). The LIP/BELF11 group showed significantly reduced alveolar bone loss on the mesial side compared to the LIP/PBS group. Histologically, the LIP/BELF11 group showed consistent patterns of connective tissue fiber arrangement, lower levels of inflammatory infiltration, less alveolar bone loss, and higher alveolar bone density than the LIP/PBS group, despite showing more signs of destruction than the CTL group. The LIP/BELF11 group also exhibited significantly lower levels of pro‐inflammatory cytokines than the LIP/PBS group.
Conclusions
L. fermentum BELF11 inhibits alveolar bone loss and periodontitis progression by regulating pro‐inflammatory cytokine production. These findings suggest that L. fermentum BELF11 may be a potential adjunctive therapy in periodontal treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology and Research Institute of Oral Sciences, Gangneung-Wonju National University College of Dentistry, Gangneung, Republic of Korea.
- Department of Anatomy and Research Institute of Oral Sciences, Gangneung-Wonju National University College of Dentistry, Gangneung, Republic of Korea.
- R&D Center, Hecto Healthcare Co., Ltd, Seoul, Republic of Korea.
ORCID-Profile: Yuni Lee, Bo Hyun Jung, Ki-Yeon Yoo, Hye Ji Lim, Kum-Joo Shin, Jae-Kwan Lee
Förderung
- Hecto Healthcare Co., Ltd
Zitieren
APA
Lee, Y., Jung, B. H., Yoo, K. Y., Lim, H. J., Shin, K. J., & Lee, J. K. (2024). Lactobacillus fermentum attenuates the alveolar bone loss in ligature‐induced periodontitis in mice. Oral Diseases. https://doi.org/10.1111/odi.14739
Vancouver
Lee Y, Jung BH, Yoo KY, Lim HJ, Shin KJ, Lee JK. Lactobacillus fermentum attenuates the alveolar bone loss in ligature‐induced periodontitis in mice. Oral Diseases. 2024. doi:10.1111/odi.14739
BibTeX
@article{Lee2024,
author = {Lee, Yuni and Jung, Bo Hyun and Yoo, Ki-Yeon and Lim, Hye Ji and Shin, Kum-Joo and Lee, Jae-Kwan},
title = {Lactobacillus fermentum attenuates the alveolar bone loss in ligature‐induced periodontitis in mice},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14739}
}
EUVIMED